A survey done by Federation of Indian Chambers of Commerce and Industry (FICCI) has stated that the prevailing political turmoil between Ukraine and Russia which has led to political and economic tensions in the Crimean region, could hit the businesses of leading Indian pharmaceutical companies. The chamber has noted that though the ongoing political crisis in Ukraine is still to impact the businesses of domestic pharma firms based in Ukraine, but if the situation continues then it could depreciate Ukraine’s currency which would make the landed cost of Indian pharmaceuticals higher. Ukraine’s currency Hryvnia depreciated about 20 percent against the dollar since mid-December on account of standoff between Russia and Ukraine.
At present, Ukraine is India’s second largest trading partner in the Commonwealth of Independent States (CIS) region after Russia and is also the gateway for country’s exports to a number of other CIS countries. In the previous fiscal, Ukraine accounted for around 30 percent of the total $154 billion exports of pharmaceutical goods.
India’s total trade with Ukraine stood at about $3.18 billion last year. However, during current fiscal India's bilateral trade with Ukraine would be around $2 billion facing a shortfall of about 37 percent as compared to last fiscal year. Ongoing political turmoil in Ukraine would also prove a setback to the recent efforts being taken by Commerce Ministry to promote exports to former members of the erstwhile Soviet Union. Ministry had decided to organize 14 India shows in the next 14 months in the key countries of CIS region to enhance exports.
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: